Qureator develops micro-physiological systems (MPS) designed to improve the accuracy of clinical trials by providing ideal microscale cell culture conditions.

Vision and Mission: Qureator’s vision is to enhance drug development efficiency and reduce reliance on animal testing. Their mission is to provide systems that accurately recapitulate tissue microenvironments, leading to more efficient and faster drug development.

Noteworthy Points:

• Founded in 2017 with a focus on healthcare technology
• Offers Curiochips, a microfluidic technology for disease investigation and drug screening
• Aims to improve clinical trial accuracy and speed